Search Results - "BIERLING, P"

The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease by Noizat-Pirenne, F., Habibi, A., Mekontso-Dessap, A., Razazi, K., Chadebech, P., Mahevas, M., Vingert, B., Bierling, P., Galactéros, F., Bartolucci, P., Michel, M.

“…Background Delayed haemolytic transfusion reaction (DHTR) is mainly caused by an immune response to transfused red blood cells (RBCs). Immunized patients have…”
Get full text

Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease by Noizat-Pirenne, F, Bachir, D, Chadebech, P, Michel, M, Plonquet, A, Lecron, J.-C, Galacteros, F, Bierling, P

“…1 Etablissement Français du Sang, Ile de France, Hôpital Henri Mondor, Créteil; 2 Centre de Référence des Cytopénies Auto-Immunes, Hôpital Henri Mondor,…”
Get full text

Transfusion of platelet concentrates by Bierling, P

“…Although a number of research have been realized in the aim to rationalize the use of platelet concentrates, these blood products remain absolutely necessary…”
Get full text

Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody‐mediated transfusion‐related acute lung injury by Bierling, P., Bux, J., Curtis, B., Flesch, B., Fung, L., Lucas, G., Macek, M., Muniz‐Diaz, E., Porcelijn, L., Reil, A., Sachs, U., Schuller, R., Tsuno, N., Uhrynowska, M., Urbaniak, S., Valentin, N., Wikman, A., Zupanska, B.

“…Background  Transfusion‐related acute lung injury (TRALI) is currently one of the most common causes of transfusion‐related major morbidity and death. Among…”
Get full text

Rare and transient anti-D antibody response in D− liver transplant recipients transfused with D+ red blood cells by Burin des Roziers, N., Ibanez, C., Samuel, D., Francoz, C., Idri, S., François, A., Mortelecque, R., Bierling, P., Pirenne, F.

“…A retrospective analysis was conducted on 20 D− liver transplant (LT) recipients transfused with D+ RBCs perioperatively and screened for RBC antibodies…”
Get full text

Blood donor hemovigilance: impact for donor and recipient safety by Hauser, L, Beyloune, A, Simonet, M, Bierling, P

“…Since its creation in 1993, hemovigilance has an important place for blood safety. The part concerning donors, as the name suggests, targeted on improvement of…”
Get more information

Thrombocytopenia and pregnancy by Khellaf, M, Loustau, V, Bierling, P, Michel, M, Godeau, B

“…The occurrence of thrombocytopenia during pregnancy is frequent (about 10%). Etiologies of thrombocytopenia are dominated by the gestational thrombocytopenia…”
Get full text

Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases by Arnal, Christophe, Piette, Jean-charles, Léone, Jean, Taillan, Bruno, Hachulla, Eric, Roudot-Thoraval, F, Papo, Thomas, Schaeffer, Annette, Bierling, Philippe, Godeau, Bertrand

“…OBJECTIVE: To evaluate the response to treatment in a large cohort of patients with systemic lupus erythematosus (SLE) associated with autoimmune…”
Get full text

Anti-T haemolysins: the effects of sialic acid removal and 2-aminoethylisothiouronium bromide treatment of erythrocytes on immune lysis by des Roziers, N. Burin, Bodivit, G., Chadebech, P., Nzouakou, R., Bierling, P., Noizat-Pirenne, F.

“…Background and Objectives  Intravascular haemolytic reactions are reported in red‐cell T‐activated patients after blood transfusion. The relationship between T…”
Get full text

Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on by Bierling, P., Godeau, B.

“…Autoimmune thrombocytopenic purpura is now commonly treated with high doses of intravenous immunoglobulins. Twenty‐two years after this treatment was first…”
Get full text

Treatment by autologous amniopatch of premature rupture of membranes following mid‐trimester amniocentesis by Mandelbrot, L., Bourguignat, L., Mellouhi, I. Sahraoui, Gavard, L., Morin, F., Bierling, P.

Get full text

Transfusion de concentrés plaquettaires by Bierling, P.

“…Bien que de nombreux travaux aient été réalisés pour rationaliser la transfusion de concentrés plaquettaires, ces produits restent largement utilisés pour les…”
Get full text

A UMLS-based knowledge acquisition tool for rule-based clinical decision support system development by Achour, S L, Dojat, M, Rieux, C, Bierling, P, Lepage, E

“…Decision support systems in the medical field have to be easily modified by medical experts themselves. The authors have designed a knowledge acquisition tool…”
Get full text

Mesenchymal stromal cells: Biological properties and clinical prospects by Roux, S, Leotot, J, Chevallier, N, Bierling, P, Rouard, H

“…Mesenchymal stromal cells are defined as non-hematopoietic progenitors characterised by their adherence to plastic in culture, their expression of non-specific…”
Get more information

Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply by Meunier, N, Rodet, M, Bonin, P, Chadebech, P, Chami, B, Lee, K, Habibi, A, Bachir, D, Galactéros, F, Bierling, P, Noizat-Pirenne, F

“…Prevention of hemolytic transfusion reactions depends upon our capacity to prevent allo-immunization and conflicts between antigens of transfused red blood…”
Get full text

Platelet-specific alloantigens and antibodies in Tunisian women after three or more pregnancies by Skouri, H., Gandouz, R., Kraiem, I., Dridi, H., Bibi, M., Khairi, H., Jemmali, M., Bierling, P.

“…Pregnancy may allow alloimmunization against human platelet antigens (HPA), which can lead to neonatal alloimmune thrombocytopenia (NAIT). The specificities of…”
Get full text

CD36 deficiency is frequent and can cause platelet immunization in Africans by Lee, K., Godeau, B., Fromont, P., Plonquet, A., Debili, N., Bachir, D., Reviron, D., Gourin, J., Fernandez, E., Galactéros, F., Bierling, P.

“…BACKGROUND: CD36 is expressed on several cell lineages. About 5 to 10 percent of Asians lack platelet membrane CD36 (pCD36), but the frequency of pCD36…”
Get full text

Xg gene frequencies in Tunisia by Gandouz, R, Kraiem, I, Bierling, P, Skouri, H

“…We report a new case of anti-Xg(a) antibody found in a man who, after receiving six units of standard red blood cells, developed a minor nonhemolytic…”
Get full text

Hémovigilance donneur : quel apport pour la sécurité du donneur et du receveur by Hauser, L., Beyloune, A., Simonet, M., Bierling, P.

“…Depuis sa création en 1993, l’hémovigilance est au cœur de la sécurité transfusionnelle. Sa composante donneurs, bien que ciblée comme son nom l’indique sur…”
Get full text

Treatment of severe fetomaternal alloimmune thrombocytopenia with compatible frozen-thawed platelet concentrates by Lee1, K., Beaujean2, F., Bierling1, P.

Get full text